Elizabeth A. Laughton
Elizabeth Laughton focuses her practice on patent litigation in a variety of technologies, including pharmaceutical Abbreviated New Drug Application (ANDA) litigation. She also prepares and prosecutes patent applications in the fields of biotechnology and business methods, and assists clients with strategic counseling.
Prior to law school, Ms. Laughton worked in drug development for new tuberculosis drugs.
- Served as a law clerk to the Honorable Timothy B. Dyk, U.S. Court of Appeals for the Federal Circuit, 2009-2010.
- ePlus, Inc. v. Lawson Software, Inc. (Fed. Cir.). Represented Lawson as defendant-appellant. Federal Circuit determined that ePlus was not entitled to any damages and reversed district court's findings of infringement on four of the five patent claims, finding two invalid and two not infringed, with result that Lawson's main software product is now clear of any infringement claim.
- Galderma Labs. v. Tolmar Inc. (D. Del.). Involved in successfully representing Galderma in an ANDA litigation for Differin® 0.3%, Gel against generic drug manufacturers asserting multiple invalidity and unenforceabilty defenses.
- Successful pro bono work representing disabled American veterans before the U.S. Court of Appeals for Veteran Claims.
- Genaro Vazquez-Claudio v. Shinseki (Fed. Cir.). Argued appeal for disabled American veteran before the U.S. Court of Appeals for the Federal Circuit. Decision pending.
- Served on the Duke Law Journal, 2007-2009: staff editor, 2007; online editor, 2008.
- Served on the Duke Law and Technology Review; 2007-2009: staff editor, 2007; content editor, 2008.
- American Intellectual Property Law Association
- Giles S. Rich Inn of Court